Status:
COMPLETED
ConnectedHeartHealth - Heart Failure Readmission Intervention
Lead Sponsor:
LifeBridge Health
Collaborating Sponsors:
American Heart Association (AHA)
Conditions:
Diabetes Mellitus
Coronary Artery Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a single-center, pilot study that will evaluate the effectiveness of the AHA science based CarePlans and the Ambio Health technology in improving the risk adjusted 30 day readmissions rate, pa...
Detailed Description
A key strategy of the Affordable Care Act is the Accountable Care Organization, designed to improve the quality of care, promote population health and reduce costs by making healthcare providers more ...
Eligibility Criteria
Inclusion
- Has a diagnosis of Heart Failure as measured by the New York Heart Association (NYHA) functional classification and is currently in functional class II- IV status.
- Have been hospitalized for an episode of acute HF decompensation within the last 30 days.
- Have access to the internet.
- Are physically and mentally capable to complete the monitoring process or have a caregiver capable of assisting in the use of the Ambio Health system.
- Willing and able to sign an informed consent form to participate in this evaluation for a duration of 180 days.
Exclusion
- Have a life expectancy of less than six months.
- Live in a nursing home other multi-member assisted living facility
- Intend to be away from their home for more than 2 weeks (14 days) total during the monitoring period.
- Are unable to read English at a minimum 5th grade level
Key Trial Info
Start Date :
November 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 9 2017
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03247608
Start Date
November 1 2015
End Date
October 9 2017
Last Update
March 1 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sinai Hospital of Baltimore
Baltimore, Maryland, United States, 21215